Evaxion Biotech: Funding, Investors & Team (Sep 2026)
Evaxion Biotech A/S is a company in the clinical stage that uses AI-immunology™ platform to understand the human immune system in order to create new immunotherapies for cancer and infectious diseases. They are working on a variety of product candidates, including personalized cancer immunotherapies that are currently in Phase I/IIa clinical trials, and vaccines for bacterial and viral infections, such as Methicillin-resistant S. aureus.
Evaxion Biotech has raised $40.1M across 3 funding rounds on record, the most recent an undisclosed round of $80k announced in Jun 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Evaxion Biotech Company Profile and Key Stats
Latest funding round on record: Jun 2025.
Evaxion Biotech Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Evaxion Biotech raised $40.0M in a Post-IPO Equity announced in Jun 2022.
3 months later, a Grant was announced in Sep 2022 with no disclosed amount.
2.8 years later, an undisclosed round of $80k was announced in Jun 2025.
Evaxion Biotech Founders and Leadership Team
No contact details are on record for this team yet.
Evaxion Biotech Funding Compared to Other Biotechnology Startups
Evaxion Biotech's latest round of $80k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Evaxion Biotech in Biotechnology and Copenhagen
Companies Similar to Evaxion Biotech
Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several…
Alcolase is a Danish life science start-up that specializes in alcohol flushing.
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on…
ENZIDIA is unleashing the biomanufacturing revolution with an enzyme acceleration revolution
Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat…
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly…
Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The…
Pioneering new sustainable bio-based ingredients
Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or…
EvodiaBio is a company in the bio-industrial sector that develops eco-friendly fragrances for the food and…
Fida Biosystems is a technology that provides the detection and characterization of proteins and…
Chromologics is a company that creates new and original food colorings utilizing natural ingredients. Derived…
Evaxion Biotech Funding FAQs
What does Evaxion Biotech do?
Evaxion Biotech A/S is a company in the clinical stage that uses AI-immunology™ platform to understand the human immune system in order to create new immunotherapies for cancer and infectious diseases. They are working on a variety of product candidates, including personalized cancer immunotherapies that are currently in Phase I/IIa clinical trials, and vaccines for bacterial and viral infections, such as Methicillin-resistant S. aureus.
How much funding has Evaxion Biotech raised?
Evaxion Biotech has raised $40.1M across 3 rounds on record. The most recent is an undisclosed round of $80k announced in Jun 2025.
When did Evaxion Biotech last raise funding?
Evaxion Biotech's most recent funding round on record is an undisclosed round of $80k, announced in Jun 2025.
Who founded Evaxion Biotech?
FundedIQ lists Andreas Holm Mattsson (Founder) at Evaxion Biotech.
Where is Evaxion Biotech headquartered?
Evaxion Biotech is based in Copenhagen, Hovedstaden, Denmark.
How many employees does Evaxion Biotech have?
Evaxion Biotech is in the 51-100 employee band.
How does Evaxion Biotech's funding compare to other Biotechnology startups?
Evaxion Biotech's latest round of $80k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Evaxion Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Evaxion Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.